Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature

@article{Tanabe2017EfficacyOV,
  title={Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature},
  author={Hiroki Tanabe and Katsuyoshi Ando and Kiichi Sato and T. Ito and Mitsuru Goto and Tomonobu Sato and Akihiro Fujinaga and Toru Kawamoto and Tatsuya Utsumi and Nobuyuki Yanagawa and Eiichiro Ichiishi and Takaaki Otake and Yutaka Kohgo and Yoshiki Nomura and Nobuhiro Ueno and Hiroko Sugano and Shin Kashima and Kentaro Moriichi and Mikihiro Fujiya and Toshikatsu Okumura},
  journal={Digestive Diseases and Sciences},
  year={2017},
  volume={62},
  pages={3069-3076}
}
Eradication therapies for Helicobacter pylori infection are advancing as new acid inhibitory reagents approved. The aim of this study was to assess the efficacy and safety of vonoprazan-based triple treatment. Triple therapy with vonoprazan and two antibiotics (amoxicillin and clarithromycin or metronidazole) received focus in this analysis. We performed a multicenter retrospective study of patients who received vonoprazan-based eradication therapy between February 2015 and February 2016 and… CONTINUE READING